BioCentury
ARTICLE | Clinical News

Prurisol abacavir acetate: Completed Phase I enrollment

June 9, 2014 7:00 AM UTC

Cellceutix completed enrollment of about 18 healthy volunteers in a 2-part, open-label, crossover, U.S. Phase I bioequivalence trial to compare oral Prurisol vs. Ziagen abacavir sulfate. Subjects wil...